L-Tyrosine


CAS No. : 60-18-4

(Synonyms: Tyrosine)

60-18-4
Price and Availability of CAS No. : 60-18-4
Size Price Stock
100g $11 In-stock
500g $35 In-stock
1000g $57 In-stock
> 2 kg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-N0473
M.Wt: 181.19
Formula: C9H11NO3
Purity: >98 %
Solubility: 1M HCl : 50 mg/mL (ultrasonic);DMSO : < 1 mg/mL;0.1 M HCL : 25 mg/mL (ultrasonic)
Introduction of 60-18-4 :

L-Tyrosine is a non-essential amino acid which can inhibit citrate synthase activity in the posterior cortex. IC50 & Target: Citrate synthase[1] In Vitro: L-Tyrosine inhibits citrate synthase activity in the posterior cortex (2.0 and 4.0 mM), malate dehydrogenase is not altered by L-Tyrosine and succinate dehydrogenase is increased in the posterior cortex (0.1-4.0 mM), hippocampus (1.0-4.0 mM), striatum (4.0 mM) and liver (0.1-4.0 mM). When complex I activity is analyzed, inhibition is observed in hippocampus (4.0 mM). In addition to inhibition in the hippocampus, complex II also is inhibited in the posterior cortex (0.1-4.0 mM) and liver (1.0, 2.0 and 4.0 mM). For complex II–III, activity is not altered by L-Tyrosine, and complex IV activity has decreased in the posterior cortex (1.0-4.0 mM) following treatment with L-Tyrosine[1]. In Vivo: The acute administration of L-Tyrosine inhibits the activity of citrate synthase in the posterior cortex and liver; however, in the striatum, the activity is increased. The results also demonstrate that acute administration of L-Tyrosine inhibits malate dehydrogenase and complex II, II–III and IV of the mitochondrial respiratory chain activity in the posterior cortex and liver of rats. The succinate dehydrogenase enzyme and complex I activity are inhibited in the posterior cortex and increased in the striatum. Furthermore, energy metabolism in the hippocampus is not amended by an acute administration of L-Tyrosine[1].

Your information is safe with us.